AQR Capital Management
CLPT icon

AQR Capital Management’s ClearPoint Neuro CLPT Stock Holding History

AQR Capital Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-13,614
Closed -$242K – 2211
2021
Q3 		$242K Buy
+13,614
New +$255K ﹤0.01% 2101

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.19B AUM 20.87% 1-Year Est. Return
GPC
Guardian Point Capital Charlottesville, Virginia $243M AUM 22.43% 1-Year Est. Return

AQR Capital Management's CLPT Position: Q4 2021 in Review

AQR Capital Management sold out of ClearPoint Neuro (CLPT) in Q4 2021, closing a stake of 13,614 shares — an estimated $242K sold.

AQR Capital Management first reported a position in CLPT in Q3 2021 and held it in 1 quarter. The position peaked at $242K in Q3 2021. 67 funds tracked by Wall St. Rank hold CLPT as of Q4 2021.

  • AQR Capital Management reported no remaining ClearPoint Neuro position as of Q4 2021 after selling out during the quarter.
  • AQR Capital Management sold 13,614 ClearPoint Neuro shares in Q4 2021, an estimated $242K.
  • AQR Capital Management first reported a position in ClearPoint Neuro in Q3 2021 and held it in 1 quarter.
  • AQR Capital Management's ClearPoint Neuro position peaked at $242K in Q3 2021.
  • 67 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q4 2021.

Based on AQR Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.